Amylin Pharmaceuticals Inc. Newsletter
-
Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
26 Mar 2024 12:51 GMT
… Bradbury’s leadership as CEO, Amylin Pharmaceuticals, with partner Alkermes, secured the …
-
GLP-1 Receptor Agonist Market Analysis: Current Trends, Future Prospects, and Competitive Landscape By 2024-2031: Sanofi
18 Mar 2024 10:52 GMT
… ., Ltd.,
◘ AstraZeneca
◘ Intarcia Therapeutics Inc.
◘ Amylin Pharmaceuticals Inc.
◘ Sanofi
◘ Hanmi Pharm. Co …
-
Pharmaceutical and Biotechnology Royalty Rates Report and Directory 2024: Technology Licensed, License Fees, Upfront and Milestone Payments for Deals Signed Since 2020 - ResearchAndMarkets.com
13 Mar 2024 13:11 GMT
… Sciences
Ampio Pharmaceuticals
Amryt Pharma
Amylin Pharmaceuticals
Amyris
AnaBios
AnaptysBio
AnGes MG …
-
Vivani Medical Appoints Daniel Bradbury to its Board of Directors
06 Mar 2024 13:15 GMT
… Executive Officer, and Director of Amylin Pharmaceuticals, a biopharmaceutical company focused on …
-
GLP1ra’s beyond obesity and diabetes: Is the sky the limit?
26 Feb 2024 13:18 GMT
… to market a GLP1ra drugs. Amylin Pharmaceuticals and AstraZeneca were the first …
-
Velia Therapeutics Appoints Michael York as Chief Business Officer
15 Dec 2023 08:19 GMT
… roles of increasing responsibility at Amylin Pharmaceuticals, Santarus, Amgen, AstraZeneca, and Merck …
-
Resilience makes good on ex-AZ plant expansion
14 Dec 2023 19:41 GMT
… $5.3 billion acquisition of Amylin Pharmaceuticals.
For Resilience, a biopharma services …
-
RespireRx Pharmaceuticals Inc. Announces Agreement with Ponto Ventures to Drive Business Development with Will Clodfelter as RespireRx Part-Time Senior VP of Business Development
11 Dec 2023 13:30 GMT
… Business Development. He was at Amylin Pharmaceuticals in New Product Planning and …